ISTANBUL OZEL AMERIKAN ROBERT LISESI – Trademark Portfolio

Entity Type: 99

ISTANBUL OZEL AMERIKAN ROBERT LISESI holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SIGILL COLL ROBERT ISTANBUL MDCCCLXIII ROBERT COLLEGE 1863. The owner is based in Besiktas Istanbul.

Arnavutkoy Besiktas

Besiktas Istanbul 34345 , TR

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ISTANBUL OZEL AMERIKAN ROBERT LISESI's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does ISTANBUL OZEL AMERIKAN ROBERT LISESI have?

ISTANBUL OZEL AMERIKAN ROBERT LISESI has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does ISTANBUL OZEL AMERIKAN ROBERT LISESI file in?

ISTANBUL OZEL AMERIKAN ROBERT LISESI files trademarks across 1 Nice Classification class. The most active classes are Class 41 (Education & Entertainment). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are ISTANBUL OZEL AMERIKAN ROBERT LISESI's most well-known trademarks?

ISTANBUL OZEL AMERIKAN ROBERT LISESI's registered trademark portfolio includes well-known marks such as SIGILL COLL ROBERT ISTANBUL MDCCCLXIII ROBERT COLLEGE 1863. These are among 1 currently registered trademark in the portfolio.

What is ISTANBUL OZEL AMERIKAN ROBERT LISESI's trademark registration success rate?

ISTANBUL OZEL AMERIKAN ROBERT LISESI has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.